Australia Toughens Code On Pharma’s Financial Ties To Doctors
This article was originally published in PharmAsia News
Executive Summary
From the beginning of this month, Australian pharmaceutical companies will be required to collect information about any payments they make to health care professionals for consulting services and any financial support they provide for educational purposes, including airfares, accommodation and conference registration fees.